Back to search results

A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.

Abroad (travel likely)RecruitingPHASE3

Conditions

RSV Infections · RSV Immunisation · Preterm Labour

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Kintampo Health Research Centre, Kintampo, Bono East, Ghana

    Contact: Study coordinator (Kwaku Poku Asante) · kwakupoku.asante@kintampo-hrc.org · +233 20 931 9145
    Contact: Principal Investigator (Kwaku Poku Asante)

  • Dodowa Health Research Centre, Dodowa, Greater Accra Region, Ghana

    Contact: Study coordinator (George Armah) · GArmah@noguchi.ug.edu.gh · +233244167999
    Contact: Principal Investigator (George Armah)

  • Kenya Medical Research Institute Wellcome Trust, Kilifi, Kilifi County, Kenya

    Contact: Study coordinator (Joyce Nyiro) · jnyiro@kemri-wellcome.org · +254724895735
    Contact: Principal Investigator (Joyce Nyiro)

  • Kenya Medical Research Institute Centre for Global Health Research, Kisumu, Nyanza, Kenya

    Contact: Study coordinator (Nancy Otieno) · notieno@kemri.go.ke · (057) 2022983
    Contact: Principal Investigator (Nancy Otieno)

  • Wits RHI Shandukani CRS, Hillbrow, Gauteng, South Africa

    Contact: Study coordinator (Lee Fairlie) · lfairlie@wrhi.ac.za
    Contact: Principal Investigator (Lee Fairlie)

  • VIDA Nkanyezi Research Unit, Johannesburg, Gauteng, South Africa

    Contact: Study coordinator (Renate Strehlau) · renate.strehlau@wits.ac.za · +27114709214
    Contact: Principal Investigator (Renate Strehlau)

  • Setshaba Research Centre, Soshanguve, Gauteng, South Africa

    Contact: Study coordinator (Patience Kwedza) · pkwedza@setshaba.org.za · +27127992422
    Contact: Principal Investigator (Patience Kwedza)

  • Wits Vaccines & Infectious Diseases Analytics (VIDA) Research unit, Soweto, Gauteng, South Africa

    Contact: Study coordinator (Johann Greffrath) · johann.greffrath@wits-vida.org · +27119834283
    Contact: Principal Investigator (Johann Greffrath)

  • Enhancing Care Foundation, Durban, KwaZulu-Natal, South Africa

    Contact: Study coordinator (Rosie Mngqibisa) · mngqibisa@ecarefoundation.com · +27312611093
    Contact: Principal Investigator (Rosie Mngqibisa)

  • MRC Unit on Child and Adolescent Health, Rondebosch, Western Cape, South Africa

    Contact: Study coordinator (Heather Zar) · heather.zar@uct.ac.za · +27216585324
    Contact: Principal Investigator (Heather Zar)

  • MRC Unit The Gambia at London School of Hygiene & Tropical Medicine, Basse Santa Su, Upper River Division, The Gambia

    Contact: Study coordinator (Grant Mackenzie) · gmackenzie@mrc.gm · (+220) (0) 4495835
    Contact: Principal Investigator (Grant Mackenzie)
Study leads

  • Shabir Madhi

    Study Chair

    Wits Vaccines & Infectious Diseases Analytics Research Unit

  • Ziyaad Dangor

    Study Director

    Wits Vaccines & Infectious Diseases Analytics Research Unit

View source on ClinicalTrials.gov(opens in a new tab)